Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Tables)

v3.22.2
Revenue from Contracts with Customers (Tables)
9 Months Ended
Jun. 30, 2022
Revenue from Contracts with Customers [Abstract]  
Revenue from Customers by Products

Three Months Ended

Nine Months Ended

June 30,

June 30,

2022

2021

2022

2021

FC2

U.S. prescription channel

$

6,736,158

$

13,501,862

$

29,900,890

$

32,916,343

Global public health sector

2,866,037

4,153,730

6,864,831

11,833,894

Total FC2

9,602,195

17,655,592

36,765,721

44,750,237

PREBOOST®

862,831

Net revenues

$

9,602,195

$

17,655,592

$

36,765,721

$

45,613,068

Revenue by Geographic Area

Three Months Ended

Nine Months Ended

June 30,

June 30,

2022

2021

2022

2021

United States

$

7,024,786

$

14,080,810

$

30,780,271

$

35,049,646

Other

2,577,409

3,574,782

5,985,450

10,563,422

Net revenues

$

9,602,195

$

17,655,592

$

36,765,721

$

45,613,068